Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
J Addict Med
; 14(6): e287-e289, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-1020285
ABSTRACT
Globally, there are concerns about access to healthcare and harm reduction services for people who use drugs (PWUD) during the coronavirus disease 2019 (COVID-19) pandemic. Members from the Network of Early Career Professionals working in Addiction Medicine shared their experiences of providing treatment to PWUD during the COVID-19 pandemic. Drawing on these qualitative reports, we highlight the similarities and discrepancies in access to services for PWUD in 16 countries under COVID-10 restrictions. In most countries reported here, efforts have been made to ensure continued access to services, such as mobilising opioid agonist maintenance treatment and other essential medicines to patients. However, due to travel restrictions and limited telemedicine services, several Network of Early Career Professionals working in Addiction Medicine members from lower-resourced countries experienced challenges with providing care to their patients during periods of COVID-19 lock-down. The insights provided in this commentary illustrate how the COVID-19 lock-down restrictions have impacted access to services for PWUD.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Substance-Related Disorders
/
Health Services Accessibility
Type of study:
Observational study
/
Qualitative research
Limits:
Humans
Language:
English
Journal:
J Addict Med
Year:
2020
Document Type:
Article
Affiliation country:
ADM.0000000000000753
Similar
MEDLINE
...
LILACS
LIS